Release Date: 19/11/09 11:01 Summary: Chairman's Address to AGM Price Sensitive: No Download Document 271.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%